Editor's words for the Year 2026

Founded by the Serican Academy of Urology (SAU) on November 2, 2024, the Serican Journal of Medicine (SJM) completed its first full year of publication in 2025. During this inaugural year, the journal published a total of 61 articles, including 14 original research articles, 2 short reports, 32 reviews and commentaries, 5 case reports, and 8 news articles.

Collectively, these publications generated 17,231 downloads from 36,340 unique visitors across 4,265 cities worldwide, with the highest readership originating from Los Angeles, Hong Kong, Chicago, Dallas, and New York. SJM has featured research spanning a broad range of topics in global medical science, including cancers such as prostate, ovarian, colorectal, lung cancers, and leukemia, as well as autoimmune diseases and gut microbiome research.

In addition, SJM places strong emphasis on technological innovation in biomedical research and has published original research and reviews on topics such as ChIP-seq normalization, Oxford Nanopore long-read sequencing, and AI-driven drug development. The most viewed article, entitled “The hTERT N-terminal DNA binding is necessary but not sufficient for maintaining telomere and cellular immortalization,” was downloaded 1,015 times and can be accessed at HERE.

The continued growth of SJM is made possible by the steadfast support of colleagues worldwide across cancer biology, medical oncology, urology, and other medical disciplines, including their willingness to submit their work to the journal and their generosity in contributing time and expertise to the peer-review process. We extend our deepest gratitude to the authors for choosing SJM as the venue for their research, to the members of the editorial board for their dedicated professional service, and to the reviewers for their rigorous and fair evaluations, which are essential to maintaining the journal’s high academic standards.

As SJM enters its second full year of publication, 2026 represents a pivotal period as we pursue official indexing in PubMed. While SJM articles are already indexed in Google Scholar and several other databases, and manuscripts reporting research funded by the National Institutes of Health may currently obtain PubMed citations on an individual basis, achieving full PubMed indexing remains a key strategic priority. In the coming year, we look forward to continued collaboration with our authors, editors, and reviewers to publish high-quality research from global academic communities and to further enhance the journal’s visibility and impact on the medical sciences.

Jindan Yu, MD/PhD

SJM Editor-in-Chief

01/15/2026